Abstract 176: Genetic Ablation of Cyclophilin-D in Mice Increases Physical and Cognitive Performance During Hypoxia

Circulation ◽  
2019 ◽  
Vol 140 (Suppl_2) ◽  
Author(s):  
Jeejabai Radhakrishnan ◽  
Alvin Baetiong ◽  
Harrison Kaufman ◽  
Michelle Huynh ◽  
Angela Leschinsky ◽  
...  

Introduction: We previously reported that silencing of the mitochondrial peptidyl-prolyl isomerase Cyclophilin-D (Cyp-D) in HEK 293T cells reduces oxygen consumption (VO 2 ). In vivo Cyp-D ablation using constitutive Cyp-D knockout (KO) mice also reduced VO 2 while paradoxically increased exercise endurance, thus demonstrating increased oxygen utilization efficiency. Therefore, we hypothesized that Cyp-D KO mice will display improved physical and cognitive performance during hypoxic conditions. Methods: Two groups of 9 mice each, age and gender-matched, representing wild-type (WT) and Cyp-D KO were subjected to treadmill running first under normobaric normoxic conditions (20.9% O 2 , simulating ground level O 2 levels), and the next day under normobaric hypoxic conditions (8% O 2 simulating 7,600 meters altitude O 2 levels). Total running time and distance, V max , and work performed were measured. A separate set of 9 mice each (Cyp-D KO and WT), were subjected to behavioral assessments; a pole test to assess motor function and an elevated plus-maze test to assess anxiety levels. The tests were conducted first under normoxia and then under hypoxia. Results: Cyp-D KO mice exposed to 8% O 2 displayed increased treadmill work (12±1 vs 8±1 Joules; p =0.02) demonstrating increased exercise capacity, shorter pole-climbing time (21±3 vs 37±4 sec; p =0.006) demonstrating increased agility and cognitive function, and increased elevated plus-maze open arm time (91±31 vs 23±12 sec; p =0.046) demonstrating anti-anxiety like behavior. Conclusions: Cyp-D KO mice demonstrated increased exercise capacity, improved motor function, decreased anxiety, and improved cognitive function under hypoxia. Thus, targeting Cyp-D and modulating its activity may impact several acute and chronic conditions in which oxygen availability is limited. The increased cognitive performance could be helpful when working at low environmental O 2 levels (e.g., high-altitude, underground caves, etc.).

2019 ◽  
Vol 33 (10) ◽  
pp. 11443-11457 ◽  
Author(s):  
Jeejabai Radhakrishnan ◽  
Alvin Baetiong ◽  
Harrison Kaufman ◽  
Michelle Huynh ◽  
Angela Leschinsky ◽  
...  

2008 ◽  
Vol 294 (3) ◽  
pp. R803-R810 ◽  
Author(s):  
Chun-Min Lo ◽  
Linda C. Samuelson ◽  
James Brad Chambers ◽  
Alexandra King ◽  
Justin Heiman ◽  
...  

CCK acts peripherally as a satiating peptide released during meals in response to lipid feeding and centrally functions in the modulation of feeding, exploratory, and memory activities. The present study determined metabolic parameters, food intake, anxiety-like behaviors, and cognitive function in mice lacking the CCK gene. We studied intestinal fat absorption, body composition, and food intake of CCK knockout (CCK-KO) mice by using the noninvasive measurement of intestinal fat absorption along with quantitative magnetic resonance (QMR) imaging and the DietMax system, respectively. Additionally, exploratory and memory capacities were assessed by monitoring running wheel activity and conducting elevated plus-maze and Morris water-maze tests with these mice. Compared with wild-type (WT) littermate controls, CCK-KO mice had normal food intake, fat absorption, body weight, and body mass. CCK-KO mice ate more food than control animals during the light period and less food during the dark period. Energy expenditure was unchanged between the genotypes; however, CCK-KO mice displayed greater fatty acid oxidation. CCK-KO mice were as active as WT animals in the running wheel test. CCK-KO mice spent more time in the closed arms of an elevated plus-maze, indicative of increased anxiety. Additionally, CCK-KO mice exhibited attenuated performance in a passive avoidance task and impaired spatial memory in the Morris water maze test. We conclude that CCK is involved in metabolic rate and is important for memory and exploration. CCK is intimately involved in multiple processes related to cognitive function and food intake regulation.


Author(s):  
Manju Gari ◽  
Manisha Varshney

The understanding of dementia has evolved over 2500 years, from a vague notion of unavoidable age-related memory loss, to a present understanding of its characteristic clinical and pathologic features. Alzheimer disease (AD) symptoms include decline in cognitive function and it is most common form of dementia. In this pharmacological study two drugs Metformin and Bacopa monnieri have been tested to evaluate their efficacy in treatment of AD using Elevated Plus Maze model by evaluating effect of these drugs on learning and memory in rats. The results shown during experiments are promising by both these drugs in improvement of learning and memory in rats, and therefore could be the potential therapy in treatment of AD as well.


SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A42-A42
Author(s):  
K Sparks ◽  
R R Wehling ◽  
S Acharya ◽  
T Musliu ◽  
S Baniya ◽  
...  

Abstract Introduction 140 million people live above 2,400m worldwide. High altitude (HA) exposure can lead to sleep disruption, impaired cognitive performance, acute mountain sickness (AMS), elevated blood pressure (BP) and an increase in cardiovascular events in healthy people. Because caffeine can also increase BP, caffeine might need to be avoided at HA. Caffeine is the most widely used drug in the world but has yet to be studied extensively in hypoxic conditions. Therefore, the aim of the current study was to examine the effects of caffeine on cardiovascular variables and cognitive function at HA. Methods We conducted a non-randomized, single-blind, mixed model design at 4,300m on Mt. Everest. Thirty-three trekkers (nine females), aged 29.5±10.4 (mean±SD), ingested the study drug (placebo or 200 mg of caffeine) 1.5 hours after awakening. To control for withdrawal effects of caffeine, participants that self-reported consuming less than 47 mg of caffeine per day received the placebo while those that consumed more than that received caffeine. Cognitive function was tested using the Stroop task before and after the pill administration. BP was measured by a trained clinician using auscultatory method prior to and 30, 60 and 90 min after the pill administration. Results Caffeine improved cognitive performance when compared to the pretreatment measurement but was worse in the caffeine group prior to the pill administration when compared to the pretreatment placebo group. Additionally, caffeine did not have any major effect on BP when compared to pretreatment measures or the placebo group. Conclusion Caffeine does not seem to have an additive effect on increasing BP with HA. Additionally, because cognitive performance was worse in the chronic caffeine users prior to the pill administration, caffeine users might be more dependent on caffeine to perform optimally at HA. Based off of these data, caffeine seems to be a safe and beneficial drug at HA. Support NIH BUILD EXITO, University of Alaska Faculty Development Grant


Circulation ◽  
2021 ◽  
Vol 144 (Suppl_2) ◽  
Author(s):  
Jeejabai Radhakrishnan ◽  
Alvin Baetiong ◽  
Raul J Gazmuri

We have previously reported in HEK 293T cells and in constitutive cyclophilin-D (Cyp-D) knock-out (KO) mice that Cyp-D ablation downregulates oxygen consumption (VO 2 ) and triggers an adaptive response that manifests in higher exercise endurance with less VO 2 . This adaptive response involves a metabolic switch toward preferential utilization of glucose via the AMPK-TBC1D1 signaling nexus. We now investigated whether a similar response could be triggered in mice after acute ablation of Cyp-D using conditional KO (CKO) mice by subjecting them to treadmill exercise involving five running sessions. At their first treadmill running session, CKO mice and controls had comparable VO 2 (208.4±17.9 vs 209.1±16.8 ml/kg·min -1 ), VCO 2 (183.6±17.2 vs 184.8±16.9 ml/kg·min -1 ), and RER (0.88±0.043 vs 0.88±0.042). With subsequent sessions, CKO mice displayed more prominent reduction in VO 2 (genotype & session interaction p<0.001) with less prominent reduction in VCO 2 resulting in significantly increased RER (genotype & session interaction p=0.013). The increase in RER was consistent with preferential utilization of glucose as respiratory substrate (4.6±0.8 vs 4.0± 0.9 mg/min, p=0.003). CKO mice also performed a significantly higher treadmill work for given VO 2 expressed as a power/VO 2 ratio (7.4±0.2 x 10 -3 vs 6.7±0.2 10 -3 ratio, p=0.025). Analysis of CKO skeletal muscle tissue after completion of five treadmill running sessions showed enhanced AMPK activation (0.669±0.06 vs 0.409±0.11 pAMPK/β-tubulin ratio, p=0.005) and TBC1D1 inactivation (0.877±0.16 vs 0.565±0.09 pTBC1D1/β-tubulin ratio, p<0.05) accompanied by increased glucose transporter-4 levels consistent with activation of the AMPK-TBC1D1 signaling nexus enabling increased glucose utilization. Taken together, our study demonstrates that like constitutive Cyp-D ablation, acute Cyp-D ablation also induces a state of increased O 2 utilization efficiency, paving the way for exploring the use of a pharmacological approach to elicit the same response, which could be beneficial under O 2 limiting conditions.


2021 ◽  
Vol 12 ◽  
Author(s):  
Jeejabai Radhakrishnan ◽  
Alvin Baetiong ◽  
Raúl J. Gazmuri

We have previously reported in HEK 293 T cells and in constitutive cyclophilin-D (Cyp-D) knockout (KO) mice that Cyp-D ablation downregulates oxygen consumption (VO2) and triggers an adaptive response that manifest in higher exercise endurance with less VO2. This adaptive response involves a metabolic switch toward preferential utilization of glucose via AMPK-TBC1D1 signaling nexus. We now investigated whether a similar response could be triggered in mice after acute ablation of Cyp-D using tamoxifen-induced ROSA26-Cre-mediated (i.e., conditional KO, CKO) by subjecting them to treadmill exercise involving five running sessions. At their first treadmill running session, CKO mice and controls had comparable VO2 (208.4 ± 17.9 vs. 209.1 ± 16.8 ml/kg min−1), VCO2 (183.6 ± 17.2 vs. 184.8 ± 16.9 ml/kg min−1), and RER (0.88 ± 0.043 vs. 0.88 ± 0.042). With subsequent sessions, CKO mice displayed more prominent reduction in VO2 (genotype &amp; session interaction p = 0.000) with less prominent reduction in VCO2 resulting in significantly increased RER (genotype and session interaction p = 0.013). The increase in RER was consistent with preferential utilization of glucose as respiratory substrate (4.6 ± 0.8 vs. 4.0 ± 0.9 mg/min, p = 0.003). CKO mice also performed a significantly higher treadmill work for given VO2 expressed as a power/VO2 ratio (7.4 ± 0.2 × 10−3 vs. 6.7 ± 0.2 10−3 ratio, p = 0.025). Analysis of CKO skeletal muscle tissue after completion of five treadmill running sessions showed enhanced AMPK activation (0.669 ± 0.06 vs. 0.409 ± 0.11 pAMPK/β-tubulin ratio, p = 0.005) and TBC1D1 inactivation (0.877 ± 0.16 vs. 0.565 ± 0.09 pTBC1D1/β-tubulin ratio, p &lt; 0.05) accompanied by increased glucose transporter-4 levels consistent with activation of the AMPK-TBC1D1 signaling nexus enabling increased glucose utilization. Taken together, our study demonstrates that like constitutive Cyp-D ablation, acute Cyp-D ablation also induces a state of increased O2 utilization efficiency, paving the way for exploring the use of pharmacological approach to elicit the same response, which could be beneficial under O2 limiting conditions.


GeroPsych ◽  
2011 ◽  
Vol 24 (2) ◽  
pp. 83-92 ◽  
Author(s):  
Valentina A. Tesky ◽  
Christian Thiel ◽  
Winfried Banzer ◽  
Johannes Pantel

To investigate the effects of leisure activities on cognitive performance of healthy older subjects, an innovative intervention program was developed. Frequent participation in cognitively stimulating activities (i.e., reading, playing chess, or playing music) is associated with reduced risk of dementia. AKTIVA (active cognitive stimulation – prevention in the elderly) is an intervention program designed to enhance cognitive stimulation in everyday life by increasing cognitive stimulating leisure activities. The present study determines the effects of AKTIVA on cognitive function, mood and attitude toward aging in a sample of older participants from the general population. Several measurement instruments were used including the Alzheimer’s Disease Assessment Scale (ADAS-Cog), the Trail-Making Test (TMT), and the Memory Complaint Questionnaire (MAC-Q). Initially, the sample consisted of 307 older persons (170 female, 72 ± 7 years). The intervention was evaluated with a randomized, controlled pre-post follow-up design. Participants were randomly assigned to one of three conditions: AKTIVA intervention (n = 126), AKTIVA intervention plus nutrition and exercise counseling (n = 84), no-intervention control group (n = 97). The AKTIVA intervention consisted of 8 weekly sessions and two booster sessions after a break of 4 months. Participation in the group program resulted in positive effects on cognitive function and attitude toward aging for subassembly groups. Older persons (≥ 75 years) showed enhanced speed of information processing (by TMT Version A) (F = 4.17*, p < .05); younger participants (< 75 years) showed an improvement in subjective memory decline (by MAC-Q) (F = 2.55*, p < .05). Additionally, AKTIVA enhanced the frequency of activities for leisure activities for subassembly groups. The results of this study suggest that the AKTIVA program can be used to increase cognitively stimulating leisure activities in the elderly. Further research is necessary to identify the long-term effects of this intervention particularly with respect to the prevention of dementia.


Planta Medica ◽  
2010 ◽  
Vol 76 (12) ◽  
Author(s):  
C Sampath ◽  
M Holbik ◽  
L Krenn ◽  
V Butterweck

Sign in / Sign up

Export Citation Format

Share Document